Micropolyspora faeni is an etiologic agent of hypersensitivity pneumonitis, a disease with an ill-defined mechanism of pathogenesis. Many reports have suggested an immunologic mechanism. A number of laboratories have demonstrated a nonantibody-mediated activation of the complement cascade. This study was undertaken to define the pathway of the complement consumption induced by M. faeni. We utilized an extract of M. faeni grown on synthetic media rather than the more common double dialysis extracts. Complement consumption by this extract was easily demonstrable in the absence of detectable antibody, but was inhibited by EDTA and MgEGTA. With the exception of C1, all of the early components of the classical pathway were markedly reduced following incubation of normal human serum with this extract. C1 was poorly consumed. In addition, factor B conversion to B was not inhibited by 10 mM MgEGTA suggests that the alternative pathway may also be affected. The generation of M. faeni-dependent chemotactic factor(s) from serum demonstrates that the complement cascade is being activated rather than inhibited.
Complement-fixing antibodies to Micropolyspora faeni were measured in farmers and controls. Farmers with known or suspected farmer's lung showed significantly higher titers than control groups. Variations in titer were measured and correlated with the clinical disease.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.